Syndromic Surveillance in WA Established in 2003
Voluntary participation
16/39 counties with ≥1 facility
Establishment: Recruited by LHJ with assistance from
the Department of Health (DOH) (n=28)
RHIO contract with CDC (n=17)
Data formats:
Flat-file (1 message/24 hours)
HL7 v.2.5 (Batched every 15 min.)
Systems:
WA-hosted ESSENCE
○ ED data only
Longitudinal Database (HL7 data only)
○ ED, Inpatient, Outpatient (with labs)
Not a BioSense 1.0 participant
BioSense Approval Process
1/18 • “Official” BioSense 2.0 invite received
1/26
• Briefing document requested by DOH Leadership
4/6
• Leadership briefing:
• Approval to evaluate BioSense
• Evaluation plan requested
• Contract processing request filed
4/13 • DUA signed by WA DOH
5/7 • Signed DUA returned by ASTHO
December - April
Review of DUA
Parties involved:
• Informatics
• IT security
• Contracts
• Epidemiology
• Public Health –
Seattle & King
County
BioSense 2.0 Implementation
Briefing Paper Outline
Contact:
Purpose: Provide background and recommendations about DOH
signing a Data Use Agreement (DUA) with ASTHO, which will allow
DOH to evaluate BioSense 2.0.
Background:
Key Stakeholders & Interests:
Analysis of Alternative Actions:
ALTERNATIVE 1 – NO ACTION
ALTERNATIVE 2 – EVALUATION OF BIOSENSE
ALTERNATIVE 3 – FULL PARTICIPATION IN BIOSENSE
Recommendation:
Alternative 1: No Action
Advantages:
None
Disadvantages:
Cost of current system
Limited opportunity for
expansion
Lack of flexibility to adjust
to changing landscape
Alternative 2: Evaluation
Advantages:
Determine
compatibility with
existing infrastructure
Assess whether
BioSense 2.0 will
meet the needs of
WA
Disadvantages:
Staff resources to re-
direct data feeds
Alternative 3: Full Participation Advantages:
PHEP & ELC grant
alignment
Expansion capability
Participation in a
national model
Servers maintained
by BioSense
Access to technical
resources for set-up
BioSense meets WA
IT security standards
Web-browser
accessible
Disadvantages:
Unknown long-term
funding
TBD (based on
evaluation)
BioSense Approval Process
1/18 • “Official” BioSense 2.0 invite received
1/26
• Briefing document requested by Leadership
4/6
• Leadership briefing:
• Approval to evaluate BioSense
• Evaluation plan requested
• Contract processing request filed
4/13 • DUA signed by WA DOH
5/7 • Signed DUA returned by ASTHO
December - April
Review of DUA
Parties involved:
• Informatics
• IT security
• Contracts
• Epidemiology
• Public Health –
Seattle & King
County
BioSense 2.0 Transition and Evaluation Plan
1. Project cost and resources required (Epi, Infomatics, PHEP)
2. Project plan. Timeframe, steps and outcomes. Table 1. Transition Plan*
Table 2. Critical Performance Measures
3. What are other states doing?
4. Impact on PHEP specifically during evaluation period.
5. ESSENCE in the cloud
6. Data security
7. Costs of long term use should the evaluation be successful
Activity Staff
Involved
Timeline
2012 2013
M J J A S O N D J F M
Objective Performance Measures
BioSense Approval Process
1/18 • “Official” BioSense 2.0 invite received
1/26
• Briefing document requested by Leadership
4/6
• Leadership briefing:
• Approval to evaluate BioSense
• Evaluation plan requested
• Contract processing request filed
4/13 • DUA signed by WA DOH
5/7 • Signed DUA returned by ASTHO
December - April
Review of DUA
Parties involved:
• Informatics
• IT security
• Contracts
• Epidemiology
• Public Health –
Seattle & King
County
Data Feed Routing
WA
HIE sFTP sFTP
Flat-file HL7 v.2.5.1
HL7 v.2.5.1 HL7 v.2.5.1
HL7 v.2.5.1
sFTP
-ms
-ms
ED, Inpatient,
Outpatient, Labs
(HL7, Flat-File)
Active Hospital Recruitment
King County BioSense Challenge Grant
Late June:
Letter
○ Encourage submission of Meaningful Use (MU) compliant
syndromic surveillance data
○ Route through WA HIE to DOH
BioSense Fact Sheet
○ Details of ASTHO DUA
WA MU Syndromic Surveillance Implementation Guide
Summer/Early Fall:
In-person meetings
Passive Hospital Recruitment
DOH MU Website (coming soon)
Outline of MU test message certification process
○ Enrollment form
○ MQF Validation of A01, A03, A04, and A08
○ Submission of MQF reports & test messages
○ Establish transport mechanism (sFTP, PHINMS, HIE)
○ Submission of Meta-data Questionnaire (in process)
WA MU Implementation Guide (in process)
Syndromic Surveillance Fact Sheet
WA State Locker – Pilot Project
WA Locker (Pilot)
-ms Receiver/
Sender
Parser
Longitudinal
Data Mart HL7 Batch File
Meta-Data
Data
Warehouse
WA Locker
BioSense 2.0
Database
-ms Receiver
stunnel
stunnel
1. ESSENCE
Update File
2. BioSense 2.0
Db File
To
ADM
Longitudinal Database Structure
Core Table
Dx Table Lab Table
Simplifies to
3 view tables
linked by
Primary Key
Diagnosis Tables
Lab Tables
Core Tables
• 1 core record per visit (ED Visit &
Inpatient Admission = 2 records)
• 1 record per lab result
• 1 record per diagnosis
WA State Locker – Pilot Project
WA Locker (Pilot)
-ms Receiver/
Sender
Parser
Longitudinal
Data Mart HL7 Batch File
Meta-Data
Data
Warehouse
WA Locker
BioSense 2.0
Database
-ms Receiver
stunnel
stunnel
1. ESSENCE
Update File
2. BioSense 2.0
Db File
To
ADM
Staffing and Users WA DOH:
Epidemiologists ○ Project Manager/BioSense Admin/Message validation
○ Communicable disease & Non-infectious disease program
Informaticians ○ Transport specialist—PHINMS, sFTP, HIE
○ Testing Coordinator
○ National expert & visionary
Contracted Software Developer ○ Builds infrastructure
○ Will modify system for new data feeds
LHJs: Epidemiologists/Public Health Nurses
○ ESSENCE
○ BioSense 2.0 web interface
○ Locker access (super-users)
Challenges…
Knowledge MU
Syndromic Surveillance
Communication Internal
LHJs
Hospitals/Clinics
Staffing Sustainability
The Future
Incorporate de-identified
notifiable condition data
ESSENCE & BioSense
expansion to include inpatient
& ambulatory data (with labs)
Pearls of Wisdom…
Start early:
DUA establishment
Informational materials
Work with ALL stakeholders as early as
possible